Skip to content
The GLP-1 Verdict
Menu
Ranked #23 · Grade B−Editorial review

Mochi Health review

A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.

Visit Mochi Health Editorial review — no commercial relationship.
Semaglutide
$138/mo
Tirzepatide
$238/mo
Coverage
AZ, CO, FL, GA, IL, MA, MD, MN, NY, OR, PA, RI, TX, VA, WA
Brand-name
Compounded only

The scorecard

Mochi Health scored on our six published factors. See the methodology.

Real-world results84/100
Price honesty85/100
Prescriber access74/100
Formulary choice78/100
Cancellation fairness82/100
Member support84/100

What we like

  • Established consumer brand with dietitian coaching
  • Discloses pricing on both molecules

The caveats

  • Available in only ~15 states — the narrowest access here
  • Not LegitScript-certified; no brand-name or oral route

The verdict

Best for: Patients in its 15 covered states who want a known, dietitian-supported program. A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.

Ranked #23 of 25 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Mochi Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Mochi Health's site. Not medical advice; see our disclosure.

← Back to all rankings